The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter retrospective study of ramucirumab-containing chemotherapy for gastrointestinal neuroendocrine carcinoma patients previously treated with platinum-based chemotherapy: RAM-NEC study (WJOG13420G).
 
Hidekazu Hirano
No Relationships to Disclose
 
Yuki Matsubara
No Relationships to Disclose
 
Toshiki Masuishi
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Daiichi Sankyo (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst)
 
Saori Mishima
No Relationships to Disclose
 
Mitsuhiro Furuta
Honoraria - Bristol-Myers Squibb; Ono Pharmaceutical
 
Tomoyuki Otsuka
No Relationships to Disclose
 
Kenta Kawasaki
No Relationships to Disclose
 
Takeshi Kawakami
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Kazuhiro Yanagihara
No Relationships to Disclose
 
Takaya Shimura
No Relationships to Disclose
 
Masato Komoda
Honoraria - Eisai; Lilly Japan
 
Kozue Murayama
No Relationships to Disclose
 
Keiko Minashi
Research Funding - Astellas Pharma (Inst); MSD (Inst); Ono Pharmaceutical (Inst)
 
Yoshiyuki Yamamoto
Honoraria - Bayer; Daiichi Sankyo; Eisai; Lilly; Merck Serono; Nihonkayaku; Ono Pharmaceutical; SERVIER; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
 
Yudai Shinohara
No Relationships to Disclose
 
Shinichi Nishina
No Relationships to Disclose
 
Nobuyuki Musha
No Relationships to Disclose
 
Kyoko Kato
No Relationships to Disclose
 
Isao Oze
No Relationships to Disclose
 
Kei Muro
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Lilly; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Chugai Pharma; Ono Pharmaceutical
Research Funding - Amgen Astellas BioPharma; Astellas Pharma; Daiichi Sankyo (Inst); Gilead Sciences (Inst); Kyowa Hakko Kirin (Inst); Mediscience Planning (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Parexel International (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Solasia Pharma (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical